Answer
Stelara (ustekinumab) 130 mg concentrate for infusion is administered only as a single intravenous induction dose, infused over at least one hour under the guidance and supervision of physicians experienced in treating Crohn’s disease or ulcerative colitis.
Sources for this answer
- STELARA 130 mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 25Document updated
Sources checked